Aix Marseille Univ, CNRS, EFS, ADES, UMR 7268, Marseille, France.
Etablissement Français du Sang PACA Corse, "Biologie des groupes sanguins", Marseille, France.
Vox Sang. 2022 Oct;117(10):1137-1144. doi: 10.1111/vox.13326. Epub 2022 Jun 13.
In Western countries, blood supply agencies encounter impediments in providing blood groups defined as rare or of interest, notably for sub-Saharan African ancestry (SSAA) recipients. To establish warning levels and anticipate future blood needs, an estimate of the current carriers of rare blood groups, both potential patients or donors, is crucial but complex. Indeed, if the strict needs can be estimated in medical terms, the modalities of blood product collection must be considered from an interdisciplinary perspective, at the interface of biological data and social norms. Here, we aim to understand how legal choices and a set of representations of otherness may influence the supply of rare blood for SSAA populations. After examining these issues, considering different norms and limits that govern French society, we compare this data with those of four Western countries facing the same difficulties (United States, United Kingdom, Italy and the Netherlands). This work began as part as the reflections of Social Lab, an institutional programme created by the French Blood Establishment (EFS). How can we effectively improve the qualitative blood coverage for SSAA populations? There is no unique solution, but there are many more or less effective answers. Comparison across countries reveals a strong influence of the socio-political histories and ethical choices before technical and medical considerations. We consider that an institutional policy is required to resolve recruitment issues of SSAA donors sustainably. Lastly, we introduce a working group called the EFS Social Lab, which aims to set up a monitoring mechanism for donors and societal trends to make blood donation effective.
在西方国家,血液供应机构在提供被定义为稀有或感兴趣的血型方面遇到了障碍,特别是对于撒哈拉以南非洲血统(SSAA)的接受者。为了建立警告级别并预测未来的血液需求,对当前稀有血型携带者(包括潜在的患者或供体)进行估计至关重要,但也很复杂。实际上,如果可以从医学角度严格估计需求,那么必须从跨学科的角度考虑血液制品采集的方式,即在生物数据和社会规范的接口处。在这里,我们旨在了解法律选择和对他者的一系列表现如何影响 SSAA 人群的稀有血液供应。在研究了这些问题之后,我们考虑了不同的规范和限制,这些规范和限制制约着法国社会,并将这些数据与面临相同困难的四个西方国家(美国,英国,意大利和荷兰)的数据进行了比较。这项工作是作为法国血液机构(EFS)创建的机构计划“社会实验室”的一部分开始的。我们如何才能有效地提高 SSAA 人群的优质血液覆盖率?没有唯一的解决方案,但有许多或多或少有效的答案。国家之间的比较表明,社会政治历史和伦理选择在技术和医疗考虑之前具有很强的影响力。我们认为,需要制定一项机构政策,以可持续地解决 SSAA 供体的招募问题。最后,我们引入了一个名为 EFS 社会实验室的工作组,旨在建立一个供体和社会趋势的监测机制,以使献血有效。
Cochrane Database Syst Rev. 2022-2-1
JBI Database System Rev Implement Rep. 2015-1
Health Soc Care Community. 2018-11-27
Transfus Apher Sci. 2009-12
Transfus Med Rev. 2008-7
Transfusion. 2017-5
Immunohematology. 2016-6
Immunohematology. 2016-6
Immunohematology. 2016-6
Immunohematology. 2016-1